SE8903047L - Undecylester av n-klorofenoxiisosmoersyra och paa denna ester baserat laekemedelspreparat foer behandling av hyperlipidemi - Google Patents

Undecylester av n-klorofenoxiisosmoersyra och paa denna ester baserat laekemedelspreparat foer behandling av hyperlipidemi

Info

Publication number
SE8903047L
SE8903047L SE8903047A SE8903047A SE8903047L SE 8903047 L SE8903047 L SE 8903047L SE 8903047 A SE8903047 A SE 8903047A SE 8903047 A SE8903047 A SE 8903047A SE 8903047 L SE8903047 L SE 8903047L
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
acid
undecylestes
chlorophenoxyosoic
hyperlipidemia
Prior art date
Application number
SE8903047A
Other languages
English (en)
Swedish (sv)
Other versions
SE8903047D0 (sv
Inventor
L N Volovelsky
Original Assignee
Kh Nii Endokrinolog Ki Med I I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kh Nii Endokrinolog Ki Med I I filed Critical Kh Nii Endokrinolog Ki Med I I
Publication of SE8903047D0 publication Critical patent/SE8903047D0/xx
Publication of SE8903047L publication Critical patent/SE8903047L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8903047A 1988-01-22 1989-09-15 Undecylester av n-klorofenoxiisosmoersyra och paa denna ester baserat laekemedelspreparat foer behandling av hyperlipidemi SE8903047L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SU1988/000019 WO1989006643A1 (en) 1988-01-22 1988-01-22 UNDECYLIC ETHER n-CHLOROPHENOXYISOBUTYRIC ACID AND A PHARMACEUTICAL PREPARATION FOR TREATING HYPERLIPEMIA BASED ON IT

Publications (2)

Publication Number Publication Date
SE8903047D0 SE8903047D0 (sv) 1989-09-15
SE8903047L true SE8903047L (sv) 1989-09-15

Family

ID=21617183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903047A SE8903047L (sv) 1988-01-22 1989-09-15 Undecylester av n-klorofenoxiisosmoersyra och paa denna ester baserat laekemedelspreparat foer behandling av hyperlipidemi

Country Status (6)

Country Link
JP (1) JPH02502998A (de)
DE (1) DE3891219T1 (de)
FR (1) FR2630736B1 (de)
GB (1) GB2221681A (de)
SE (1) SE8903047L (de)
WO (1) WO1989006643A1 (de)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717669A (en) * 1968-06-18 1973-02-20 American Home Prod 2-phenoxyalkanoic acid esters
FR2085634A1 (en) * 1970-04-14 1971-12-31 Synthelabo 2-(parachlorophenoxy)-2-methyl propionic esters - hypolipemics and hypocholesterolemics
GB1422679A (en) * 1972-11-16 1976-01-28 Funai Pharmaceutical Ind Ltd Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same
NL7416412A (nl) * 1973-12-27 1975-07-01 Siegfried Ag Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
NL184308C (nl) * 1975-07-24 1989-06-16 Takeda Chemical Industries Ltd Werkwijze voor het bereiden van l-ascorbienzuurgranules.
US4326882A (en) * 1978-08-28 1982-04-27 Ppg Industries, Inc. Trichlorophenoxy alkanoic acid free of chlorinated dibenzo-p-dioxins
JPS5559140A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 3,5-dihydroxypentanoic alkyl ester derivative, its preparation and remedy for hyperlipemia containing the same as the effective component
JPS5576840A (en) * 1978-12-01 1980-06-10 Kaken Pharmaceut Co Ltd New oxyacetic acid derivative, its preparation and blood- lipid depressor containing it as active principle
SE450381B (sv) * 1979-02-08 1987-06-22 Merz & Co Estrar av nikotinsyra och 2-(p-klorfenoxi)-isosmorsyra till anvendning som lipidsenkande medel
EP0032631A3 (de) * 1980-01-16 1981-11-11 Fbc Limited Unkraut bekämpfende Derivate der Phenoxyalkansäure, ihre Herstellung, sie enthaltende Zusammensetzungen und ihre Anwendung
AT378952B (de) * 1981-12-14 1985-10-25 Arcana Chem Pharm Verfahren zur herstellung von phenoxyisobutters|ureestern
GB2142822B (en) * 1983-06-29 1987-02-11 Alec Stanley Walter Shaw Nicotine lozenges
GB8330407D0 (en) * 1983-11-15 1983-12-21 Sterwin Ag Halocyclopropyl-substituted phenoxyalkanoic acids and esters
FR2598146B1 (fr) * 1986-04-30 1989-01-20 Rech Ind Nouveau procede de preparation de fibrates.

Also Published As

Publication number Publication date
GB8920466D0 (en) 1989-11-01
FR2630736A1 (fr) 1989-11-03
GB2221681A (en) 1990-02-14
FR2630736B1 (fr) 1990-08-24
JPH02502998A (ja) 1990-09-20
SE8903047D0 (sv) 1989-09-15
WO1989006643A1 (en) 1989-07-27
DE3891219T1 (de) 1990-02-01

Similar Documents

Publication Publication Date Title
EP1736152A3 (de) Physiologisch stabile Butlersäurepräparate, und Butlersäuresalze und Derivate zur Behandlung von Wunden
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
DK227282A (da) Anti-thrombotikum baseret paa polysaccharider fremgangsmaade til dets fremstilling og farmaceutiske produkter
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
SE9002550D0 (sv) Heparinfragment
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
ATE124258T1 (de) Schilddrüsenhormone zur kardialen behandlung.
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
SE7910300L (sv) Farmaceptisk komposition for behandling av neoplastiska sjukdomar och forfarande for dess framstellning
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
IT8947616A0 (it) Preparato per il trattamento e la cura delle emorroidi
SE8903047D0 (sv) Undecylester av n-klorofenoxiisosmoersyra och paa denna ester baserat laekemedelspreparat foer behandling av hyperlipidemi
SE7905810L (sv) Spiroketaliner och deras anvendningar
NO173137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
SE7708176L (sv) Bensamidforeningar
DK675489D0 (da) Anvendelse af tpa-varianter til fremstilling af et terapeutisk praeparat til behandling af vaskulaere sygdomme
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8903047-2

Effective date: 19900907